Home > Healthcare > Biotechnology > Biotechnology R&D > U.S. Bioreactors Market

U.S. Bioreactors Market Share

Report ID: GMI10829
Published Date: Aug 2024
Report Format: PDF

Download Free Sample

U.S. Bioreactors Market Share

The U.S. bioreactor sector is competitive, featuring a mix of major and smaller to medium-sized companies vying for market share. A pivotal aspect of market strategy involves the continual introduction of innovations such as automation and process control, integrated sensors and analytics, high-density cell cultures, and hybrid U.S. bioreactors. Notably, prominent industry players wield significant influence in this dynamic landscape, often driving advancements through substantial investments in research and development. Additionally, strategic alliances, acquisitions, and mergers play a crucial role in strengthening market positions and expanding footprints amid evolving regulatory landscapes.

U.S. Bioreactors Market Companies

Some of the eminent market participants operating in the U.S. bioreactors industry include:

Altrad Group
BaiLun Biotechnology Co., Ltd
Danaher Corporation
Donaldson Company, Inc
Eppendorf Group
Esco Micro Pte. Ltd.
GEA Group Aktiengesellschaft
Getinge AB
Merck KGaA
PBS Biotech, Inc.
Sartorius AG
Thermo Fisher Scientific Inc.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The U.S. bioreactors market size was valued at around USD 3.8 billion in 2023 and is estimated to grow at 11% CAGR from 2024 to 2032, driven by the growing demand for biopharmaceuticals.

The reusable bioreactors segment in the U.S. held a revenue of USD 2.8 billion in 2023 and will grow rapidly through 2032, owing to its cost-effectiveness.

The U.S. stainless-steel bioreactors segment held a decent market share in 2023 and is anticipated to account for USD 5.5 billion by 2032, owing to its durability and robustness.

Aledade, Ariadne Labs , MyDirectives, Inc, Respecting Choices, Sharp HealthCare, VyncaCare, WiserCare among others.